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Analysis Service 
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ABSTRACT 
Background: Studies have shown marked improvements in survival between 1981 
and 2000 for Ewing sarcoma patients but not for osteosarcoma. This study aimed to 
explore socio-economic patterning in early mortality rates for both tumours.  
Procedure: The study analysed all 2432 osteosarcoma and 1619 Ewing sarcoma 
cases, aged 0-49 years, diagnosed in Great Britain 1985-2008 and followed to 
31/12/2009. Logistic regression models were used to calculate risk of dying within 
three months, six months, one year, three years and five years after diagnosis. 
Associations with Townsend deprivation score and its components were examined at 
small-area level. Urban/rural status was studied at larger regional level.  
Results: For osteosarcoma, after age adjustment, mortality at three months, six 
months and one year was associated with higher area unemployment, OR = 1·05 
(95% CI 1·00, 1·10), OR = 1·04 (95% CI 1·01, 1·08) and OR = 1·04 (95% CI 1·02, 
1·06) respectively per 1% increase in unemployment. Mortality at six months was 
associated with greater household non-car ownership, OR = 1·02 (95% CI 1·00, 1·03). 
For Ewing sarcoma, there were no significant associations between mortality and 
overall Townsend score, nor its components for any time period. For both tumours 
increasing mortality was associated with less urban and more remote rural areas.  
Conclusions: This study found that for osteosarcoma, early mortality was associated 
with residence at diagnosis in areas of higher unemployment, suggesting risk of early 
death may be socio-economically determined. For both tumours, distance from urban 
centres may lead to greater risk of early death.   
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1. Introduction 
Initiatives by the National Cancer Research Institute (NCRI), the National Cancer 
Intelligence Network (now the National Cancer Registration and Analysis service) and 
the National Awareness and Early Diagnosis Initiative (NAEDI) have highlighted the 
need for early diagnosis of cancer to improve survival [1]. Studies have suggested 
that childhood bone cancer has a longer time to diagnosis compared to some other 
childhood cancers and that a longer time to diagnosis is associated with older age for 
bone cancer in children, teenagers and young adults (TYA) [2, 3]. The TYA age (13-
24 years) group represents a unique challenge to the UK National Health Service as 
they often straddle paediatric and older adult services, experience variation in 
treatment protocols compared to younger children and have to cope with a cancer 
diagnosis during a key developmental part of their lives [4].  
 
Previous studies have analysed incidence and survival from primary bone tumours 
using data from the northern part of England. In those analyses, over the twenty year 
period from 1981 to 2000 there were marked improvements in survival from Ewing 
sarcoma for children and for all patients aged less than 40 years at time of diagnosis, 
whereas no improvements were seen in survival from osteosarcoma [5, 6]. A previous 
national study of osteosarcoma and Ewing sarcoma survival data for those aged 0-39 
years did not fully investigate geographical patterns in survival rates [7]. A study from 
Germany showed that delays in diagnosis of bone tumours may be greater for patients 
resident in rural areas [8]. Differences in survival between countries have also been 
demonstrated. A comparative survival analysis of Ewing sarcoma patients between the 
UK and Germany found that survival rates were lower for UK patients [9]. 
Furthermore, a recent study from the USA suggested that socioeconomic factors 
influence overall survival for osteosarcoma [10]. Taken together these previous 
findings suggest that there are geographically determined factors which are related to 
mortality and survival amongst patients diagnosed with bone tumours.  
 
The aims of the present study were to determine if socio-economic patterning in early 
mortality rates for osteosarcoma and Ewing sarcoma were modulated by age, gender, 
area based measures of deprivation, and residence in urban or rural areas.  This should 
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provide better understanding of the possible reasons for longer time to diagnosis in 
the UK compared to other similar countries. It should also allow the reasons for lack 
of improvement in early mortality, especially for osteosarcoma, to be elucidated.  
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2. Methods 
2.1. Study Subjects 
The study population consisted of patients diagnosed with osteosarcoma or Ewing 
sarcoma in Great Britain between 1985 and 2008. Patients were followed to 
31/12/2009 or date of death if earlier. The age range was limited to 0-49 years since 
there were very few Ewing sarcoma cases above this age and osteosarcoma over 50 
years is most often associated with Paget’s disease or is usually secondary to 
radiotherapy [11, 12].  
 
The patient data were accessed from the ten former regional cancer registries that 
covered the whole of Great Britain. Patient data from the National Registry of 
Childhood Tumours [13] were also extracted and used to cross-check accuracy of data 
for those aged 0-14 years obtained from the regional registries. Analyses of these data 
showed similar results, and thus provided reassurance regarding data accuracy. The 
necessary regulatory and ethical approvals were obtained (UK National Research 
Ethics Service reference number 11/NE/0298). 
 
2.2. Diagnostic groups 
Cases were classified into diagnosis groups using the International Classification of 
Diseases for Oncology, third edition (ICD-O-3) [14]. The coding used information on 
both morphology and topography. Two specific diagnostic groups were specified a 
priori: (i) osteosarcoma (ICD-O-3 topography codes for sites classified as bones and 
joint: C400-C403, C408-C414, C418-C419 and associated morphology codes 9180/3, 
9181/3, 9182/3, 9183/3, 9184/3, 9185/3, 9186/3, 9187/3, 9192/3, 9193/3, 9194/3, 
9195/3) and (ii) Ewing sarcoma (ICD-O-3 topography codes for sites classified as 
bones and joint: C400-C403, C408-C414, C418-C419, C760-C768 and associated 
morphology codes 9260/3, 9261/3). 
 
2.3. Outcome 
The possibility that time to diagnosis could increase in older age groups suggested 
that survival time might not be a robust outcome measure and mortality, as defined 
by the number of deaths in specified time intervals, would be more appropriate. 
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Survival was recorded in the dataset as time in days from date of diagnosis to date of 
death or 31/12/2009 if vital status was recorded as alive at that date. Extremely early 
death is unusual in bone sarcoma and therefore patients with survival time equal to 0 
days were excluded from the analysis on the assumption that their true survival time 
was unknown. Mortality at each time point after diagnosis of three months, six 
months, one year, three years and five years was calculated where vital status was 
recorded as died and survival time was not greater than 91, 182, 365, 1096, or 1826 
days respectively. 
 
2.4. Boundary data 
Widespread boundary changes impede analyses over a prolonged time span, 
particularly at the small area level. Geo-referenced bone cancer registration data were 
linked to 2001 census boundaries [15]. The census boundaries consisted of wards in 
England and Wales (0–49 population ranges from 297 to 29,300, median = 3,090) 
and postcode sectors in Scotland (0–49 population ranges from 23 to 15,916, median 
= 3,201). In England and Wales analyses were performed at the small area census 
ward level and in Scotland at the postcode sector level. The term small area unit (SAU) 
is used for convenience throughout this article. 
 
There are no formal urban/rural classifications of wards/postal sectors or other small 
areas that cover the whole of Great Britain and therefore two ways of examining the 
urban/rural nature of areas were chosen.  First, a scheme developed in 1991 by Office 
of Population Censuses and Surveys and updated by Champion and Norman was used. 
This grouped local authority areas into 13 area types ranging from ‘Inner London’ to 
‘Remoter rural’. Secondly, a measure was created using ‘persons per hectare’ (pph) in 
the following way; a SAU with >33 pph was classified as ‘Most urban’, 26-33 pph ‘Very 
urban’, 13-26 pph ‘Urban’, 1-13 pph ‘Rural’ and <1 pph ‘Most rural’. 
 
2.5. Demographic data 
Adjustment for deprivation was made using an area based, time-series of cross-
sectional indicators. These were obtained from each of the censuses during the study 
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period and geographically converted to be compatible with the 2001 SAUs [15]. The 
Townsend index is often used in similar geographical studies and comprises four 
components on unemployment, non-car ownership, non-home ownership and 
household overcrowding. To take account of any changes in deprivation for every SAU 
at the different time points, each Townsend component was expressed as a z-score 
relative to the GB average level over the study period. At each census time point, the 
z-scores were summed, equally weighted, to provide a set of deprivation scores in 
every SAU [16]. 
 
2.6. Statistical Analysis 
Logistic regression models analysed the odds of dying within three months, six 
months, one year, three years and five years after diagnosis. Three year and five year 
follow up data were only available for patients diagnosed 1985-2006 and 1985-2004 
respectively and therefore the analyses of these time periods were carried out on a 
subset of the patients analysed at the shorter time periods. 
 
Associations with a time series of Townsend deprivation score and its components 
were examined at small-area level. The ecological (independent) variables were the 
census-derived small-area characteristics, which were allocated to the 2001 census 
geography using Norman’s method [15].  
 
A series of univariable and multivariable models were fitted separately for 
osteosarcoma and Ewing sarcoma and included the following independent variables: 
sex, age group at diagnosis (0-14, 15-19, 20-39 and 40-49 years), area based 
population density, Townsend score (as a composite). The four components of the 
Townsend score (percentage of overcrowded homes, percentage of households 
without a car, percentage of persons unemployed and percentage of homes that are 
not owner occupied) were included in separate models that did not include the 
composite score. Multivariable models comprised those variables which had shown a 
statistically significant relationship with mortality in a univariable model but only fitted 
if one of the variables was a deprivation variable i.e. Townsend composite score or a 
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component. Model fit was assessed using the Akaike information criterion (AIC) with 
the final multivariable model selected as the one with the minimum AIC value. 
Interactions between age and the Townsend score and age and the individual 
Townsend components were considered for inclusion in the models. The likelihood 
ratio test was used to compare models with and without the interaction term. The 
effect of urban/rural area type on mortality was also examined using univariable 
logistic regression and then in multivariable models adjusting first for age and sex and 
then additionally but separately for Townsend score, area unemployment and non-car 
ownership in area of residence. For these latter analyses, Inner London was used as 
the baseline comparison group, because it was ranked as the ‘most urban’ of the area 
types.  Odds ratios (ORs) for the time periods from diagnosis are presented, together 
with 95% confidence intervals (CI). All analyses were carried out using STATA version 
14.   
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3. Results 
There were 2432 cases of osteosarcoma (58·2% male) and 1619 cases of Ewing 
sarcoma (60.0% male)  included in the analysis after excluding those with survival 
equal to 0 days (1·3% of each cancer type). The demographic patient and area 
characteristics of the two groups are shown in Table 1 (the Townsend deprivation 
score ranged from –5·93 to 12·22 in 1971, -6·52 to 13·44 in 1981, -6·04 to 12·34 in 
1991 and -7·32 to 7·89 in 2001). The number of diagnoses and deaths in the two 
groups are shown in Table 2. Cumulative mortality increased from 1.7% at three 
months after diagnosis to 45.4% at five years for osteosarcoma patients and 
similarly from 2.0% at three months to 49.4% at five years for Ewing sarcoma 
patients (Table 1). The percentage of patients in each age group who had died at 
each time point are shown in Figures 1a and 1b. For osteosarcoma patients there 
was little variation over time between the age groups for those aged <=39 years but 
considerably more variation in mortality between all age groups for Ewing sarcoma 
patients and notably as time elapsed. 
 
3.1. Regression analysis: osteosarcoma 
Independent effects of demographic characteristics and area deprivation on 
mortality are shown in Supplemental Table S1. There was increased mortality 
(compared to children) at three months from a diagnosis of osteosarcoma in the age 
group 20-39 years and increased mortality up to three years for the age group 40-49 
years. The impact on mortality of being diagnosed aged 40-49 years decreased over 
time, OR = 10·2 (95% CI 3·45, 29·6) at three months and OR = 1·42 (95% CI 0·99, 
2·05) at five years. There was no difference between males and females except that 
mortality was lower for females at three years, OR = 0.79 (95% CI 0.67, 0.95), and 
five years, OR = 0·76 (95% CI 0·63, 0·91). 
 
For the area deprivation variables, small but statistically significant increases in 
mortality were seen with increasing unemployment at three months, six months and 
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one year after diagnosis, increased households without a car, at six months and one 
year and an increase in the overall Townsend score, at one year.  As an example of 
the increase in mortality, the percentage of patients who died within three months of 
diagnosis increased by 5% for every one percent increase in unemployment (OR = 
1·05; 95% CI 1·01, 1·10). 
 
Multivariable logistic regression models were produced for the time points from 
diagnosis where at least one area deprivation variable had shown a significant 
association with mortality in the univariable analysis. The deprivation variable was 
adjusted for age group and sex and the models with the lowest AIC measure by time 
point are presented in Table 3 and again show a small but independent, significant 
effect of the deprivation variable after adjustment.  The likelihood ratio tests showed 
no effect of including interaction terms of age and the Townsend score (P = 0·79) or 
age and Townsend components (P = 0·39, 0·93, 0·80, 0·95 respectively for 
unemployment, home ownership, overcrowding and non-car ownership). 
 
In the models examined at six months the AIC measure for % unemployment and 
age group was little different to that for % households without a car and age group 
(0·3107 versus 0·3106). In this model the effect on mortality of living in an area 
with increased unemployment was very similar to that of increasing non-car 
ownership (OR 1·04 [95% CI 1·01, 1·08]; P = 0·02). However when both 
unemployment and non-car ownership were included in a model and adjusted for 
age group, neither variable remained statistically significant. A scatter plot 
(Supplemental Figure S1) showed that while there was a positive relationship 
between increasing unemployment and increasing non-car ownership in many areas, 
at the same time there were also many areas where non-car ownership was high but 
in contrast unemployment was low. 
 
3.2. Regression analysis: Ewing sarcoma 
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Results for the univariable regression analysis for Ewing sarcoma patients are shown 
in Supplemental Table S2. There was increased mortality (compared to children) for 
Ewing sarcoma for each time from diagnosis for the age groups 20-39 and 40-49 
years.  The effect of age on mortality decreased with elapsed time for those aged 
20-39 years but there was no trend for the older age group (40-49 years). For 
patients aged 15-19 years at diagnosis, mortality was also significantly higher than 
the youngest age group at one year, three years and five years after diagnosis. 
Mortality was not shown to be significantly related to any deprivation variable and 
therefore no multivariable model was considered. 
 
3.3. Area type analysis 
The effects of area type on mortality using the first urban/rural measure are shown 
in Figures 2a (osteosarcoma patients) and 2b (Ewing sarcoma patients). Differences 
in mortality in the osteosarcoma group seemed to appear away from the major 
urban areas and into the more remote areas. This was less apparent for the Ewing 
sarcoma group. 
 
Following these results, the effect of area type on mortality was examined further by 
adjusting for deprivation factors. Area type was firstly adjusted for age and sex to 
provide baseline measures and then additionally but separately for Townsend score, 
unemployment and non-car ownership.  
 
These analyses were carried out for the early mortality periods of three months, six 
months and one year post diagnosis. There were no interactions between area type 
and Townsend score in any time period or in either group. In both the osteosarcoma 
and Ewing sarcoma groups, there appeared to be no additional impact for 
deprivation at 3 months (data not shown). At six months for the osteosarcoma 
group, adjusting for Townsend score increased the effect of a small number of areas 
on mortality but the effect was increased to a greater extent and for an increased 
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number of areas when adjusted for non-car ownership (Supplemental Table S3). In 
contrast, for Ewing sarcoma patients, these adjustments showed no effect on 
mortality at six months. For the osteosarcoma group at one year, the effect of area 
type on mortality increased most extensively when adjusted for either Townsend 
score or non-car ownership but in general the effect was strengthened more with 
non-car ownership (Supplemental Table S4). Adjusting for deprivation factors in the 
Ewing sarcoma group on mortality at one year appeared to only have an impact on 
mortality for three area types. These were “other metropolitan cities” when adjusted 
for Townsend score, OR = 2.56 (95% CI 1·04, 6·29), “remoter urban/rural” when 
adjusted for Townsend OR = 3·40 (95% CI 1·16, 9·91) and no-car OR = 2·95 (1·01, 
8·62) and “small non-metropolitan cities” when adjusted for Townsend, OR = 3·64 
(95% CI 1·23, 10·82), unemployment OR = 3·18 (95% CI 1·09, 9·25) and no-car 
OR = 3·23 (95% CI  1·09, 9·52). Scatter plots showed differences in the relationship 
between area unemployment and non-car ownership by area type (Supplemental 
Figure S2). 
 
Using persons per hectare as a measure of urban/rural area type in the 
osteosarcoma group, showed no statistically significant differences in mortality for 
any period of follow-up between those areas with density classified as ‘very urban’, 
‘urban’, ‘rural’ or ‘very rural’ compared to ‘most urban’ (data not shown). Using the 
same measure for the Ewing sarcoma patients, again there were no statistically 
significant differences compared to ‘most urban’ areas but there did appear to be a 
trend in the ORs showing increasing mortality in less urban and more rural areas for 
all periods except three months of follow-up (e.g. one year period, ‘most urban’ OR 
= 1, ‘very urban’ OR = 0·85, ‘urban’ OR = 1·09, ‘rural’ OR = 1·11, ‘most rural’ OR = 
1·27).   
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4. Discussion 
We have identified socio-economic patterning in early mortality rates for patients aged 
0-49 years diagnosed with osteosarcoma in GB. Specifically the study found that for 
osteosarcoma, mortality at three months, six months and one year after diagnosis was 
significantly associated with residence in areas of higher unemployment. There were 
no significant associations with deprivation at three or five years post-diagnosis. There 
were also no overall significant associations between early mortality for patients 
diagnosed with Ewing sarcoma and socio-economic deprivation. However, there was 
some evidence for an effect of deprivation for certain types of area. Increased risk of 
early death for both osteosarcoma and Ewing sarcoma was linked with residence in 
less urban and more remote rural areas. There may also be a link with non-car 
ownership, though owning a car is not equally essential for access to services in all 
areas. However, the analyses were ecological and so the findings do not necessarily 
apply to individuals. The magnitudes of the effects of deprivation and urban or rural 
area type were much more pronounced for osteosarcoma than for Ewing sarcoma.  
 
For both osteosarcoma and Ewing sarcoma mortality was significantly higher in older 
age groups (20-49 years) compared to children (0-14 years). The study period, 
1985-2008, was mainly prior to the development of dedicated TYA centres in GB. 
Although specialist bone cancer centres (covering a much wider age range) were 
already well established, the availability of specialist treatment centres for children 
could have contributed to lower early mortality for this age group [17]. There are 
currently 8 bone cancer centres in England and Scotland with patients from Wales 
travelling to one of two centres in England. These centres cover a wide age range. 
In comparison, there are 18 specialist cancer treatment centres for children and 
young adults in England, Wales and Scotland [18]. There were little or no 
differences between males and females. The lack of interaction between age and 
measures of deprivation for osteosarcoma suggests that the effect of deprivation 
was similar for all age-groups.  
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There was little or no improvement in survival from osteosarcoma between 1988 and 
2007 [19]. Without major improvements in treatment strategies, delivery of the best 
available treatment is of vital importance. Key factors that impede optimal treatment 
include delays in diagnosis, compliance and access to care. All of these factors might 
be socio-economically determined. Evidence suggests that of all cancer types, the time 
from first symptom to diagnosis are longest for bone tumour patients of all ages, but 
especially for TYA [2, 20]. Some recent initiatives by the NCIN and the National 
Awareness & Early Diagnosis Initiative (NAEDI) have emphasised the importance for 
early cancer diagnosis to make improvements in patient outcomes [1]. 
 
Little research has focussed on delays in diagnosis in patients with bone tumours. 
However, socio-economic deprivation has been associated with worse survival for the 
more common cancers, including breast cancer and chronic myeloid leukaemia [21, 
22]. The poorer outcomes associated with deprivation for breast cancer were 
attributed to both diagnostic delays as well as comorbidities.  Findings from our 
present study suggested that residence in areas of greater deprivation (specifically 
areas with higher rates of unemployment) was associated with worse early mortality 
for osteosarcoma. Also, residence in less urban and more remote rural areas was 
associated with increased risk of early death for both osteosarcoma and Ewing 
sarcoma. One possible interpretation of these findings is that diagnostic delays 
(patient and/or professional) may be greater in more deprived areas. Other issues 
may also contribute including distance from a specialist treatment centre [23]. Another 
study from Germany found greater diagnostic delays in patients who were resident in 
rural areas [8]. 
 
A previous national UK study of osteosarcoma and Ewing sarcoma survival data did 
not fully investigate socio-economic patterning in survival rates [7]. Another 
comparative study found lower survival from Ewing sarcoma in UK patients compared 
with German patients [9]. This finding may be due to delays in referral or differences 
in treatment regimes. A few studies have examined the pre-diagnostic experiences 
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amongst bone cancer patients.  A retrospective interview study from a specialist centre 
in Birmingham found significant delays, which were attributed to ‘professional’ delays 
and not ‘patient’ delays [24]. However, another study of thirty patients with 
osteosarcoma around the knee from Malaysia found that delays in diagnosis was 
associated with both patient and professional delays [25].   
     
A study of adherence to leukaemia maintenance therapy amongst children, 
adolescents and adults in south-eastern France found that low socio-economic status 
was associated with non-adherence to treatment [26]. A study from Brazil found that 
low educational level, but not low income, was associated with treatment compliance 
for chronic myeloid leukaemia [27]. A study from New York City found that housing 
needs amongst ethnic minorities was associated with lack of adherence to 
radiotherapy and chemotherapy [28]. However, access to health care in these three 
countries is markedly different from the UK, which has universal health insurance 
coverage. Nevertheless studies of common cancers suggest that access to care may 
be, at least partially, socio-economically determined, as postulated by the ‘inverse care 
law’. For example, access may be determined by travel time to the treatment centre 
[29]. One study found that screening for oral cancer was inversely associated with 
lower uptake amongst those most at risk [30]. Another study from the UK found that 
routes to diagnosis for sarcoma patients differ from other cancer [31]. However, 
access to care is unlikely to be socio-economically determined for children but for 
young people (ages 15-24 years) this is not the case as only around half are seen in 
regional specialist centres [32]. There is a need for studies of both compliance and 
access to care specifically for bone tumours in order to understand fully how these 
factors affect survival.  
 
In conclusion, this novel study has used a population-based dataset with very high 
levels of case ascertainment and novel geo-coding of cases to allocate area-based 
levels of socioeconomic status. However, staging and treatment data were not 
available. The findings suggest that risk of early death may be socio-economically 
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determined in patients diagnosed with osteosarcoma. There was much less evidence 
for an effect of deprivation on early mortality from Ewing sarcoma However, for both 
osteosarcoma and Ewing sarcoma increasing mortality was associated with less urban 
and more remote rural areas, suggesting that distance from urban centres may lead 
to greater risk of early mortality. Further research is needed to fully explore the factors 
that may have led to this disparity. These include delays in diagnosis (patient or 
professional), compliance with treatment and access to care. The magnitudes of the 
disparities suggest that there is much more scope for improvement for osteosarcoma 
than for Ewing sarcoma.  
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Figure Legends 
Figure 1a. Osteosarcoma cohort: Cumulative mortality at time after diagnosis by age 
group.              (3 year and 5 year follow up restricted to those diagnosed 1985-
2006 and 1985-2004 respectively) 
Figure 1b. Ewing Sarcoma cohort: Cumulative mortality at time after diagnosis by 
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TABLE 1 - Demographic patient and area of residence characteristics for patients diagnosed with Osteosarcoma or Ewing Sarcoma 1985-2008. Mortality in 
each group by period of diagnosis 
 Osteosarcoma 
N (%) 
Ewing Sarcoma 
N (%) 
Males 
Females 
1416 (58·2) 
1016 (41·8) 
972 (60·0) 
647 (40·0) 
Age 0-14 years 
      15-19 
      20-39 
      40-49 
786 (32·2) 
699 (28·7) 
767 (31·5) 
180 (7·4) 
646 (39·9) 
406 (25·1) 
495 (30·5) 
  72 (4·5) 
 
Townsend score* 
% Unemployment 
% HH overcrowded 
% HH without car 
% HH property not owned 
Population density (0-49 years) 
Population density (All age) 
Median (IQR) (Range) 
 -1·18 (-3·01, 1·42) (-6·68, 12·34) 
  4·78 (2·94, 7·63) (0·65, 42·7) 
  1·44 (0·88, 2·57) (0, 29·79) 
28·24 (18·56, 39·79) (3·50, 90·83) 
29·50 (20·16, 43·18) (3·24, 98·48) 
15246 (5181, 29243) (16, 171820) 
22861 (7964, 42371) (25, 234751) 
Median (IQR) (Range) 
-1·17 (-3·15, 1·32) (-6·59, 10·85) 
 4·66 (2·81, 7·6) (0, 35·17) 
 1·45 (0·9, 2·61) (0, 19·74) 
27·62 (17·82, 39·6) (2·36, 84·37) 
29·25 (19·94, 42·15) (2·14, 93·69) 
14186 (3433, 27502) (13, 159033) 
21202 (5236, 39267) (22, 204625) 
Inner London 
Outer London 
Principal Metropolitan Cities 
Other Metropolitan Cities 
Large Non-metropolitan Cities 
Small non-metropolitan Cities 
Industrial Districts 
Districts with New Towns 
Resort Port and Retirement 
Accessible Urban/Rural 
Remoter Urban/Rural 
Accessible Rural 
Remoter Rural 
152 (6.3) 
214 (8.8) 
172 (7.0) 
372 (15.3) 
158 (6.5) 
93 (3.8) 
340 (14.0) 
124 (5.1) 
158 (6.5) 
337 (13.8) 
90 (3.7) 
62 (2.6) 
160 (6.6) 
62 (3.8) 
127 (7.8) 
118 (7.3) 
257 (15.9) 
113 (6.9) 
51 (3.2) 
236 (14.6) 
76 (4.7) 
78 (4.8) 
233 (14.4) 
74 (4.6) 
47 (2.9) 
147 (9.1) 
* increase in score=increase in deprivation
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TABLE 2 - Number of diagnoses and cumulative mortality in each group by period of diagnosis 
 Osteosarcoma 
N, % (95% CI) 
Ewing Sarcoma 
N, % (95% CI) 
Diagnosed 1985-2008  
  Died <=3 month 
  Died <=6 months 
  Died <=1 year 
2432 
42,  1·7 (1·3, 2·4) 
89,  3·7 (3·0, 4·5) 
277,  11·4 (10·2, 12·7) 
1619 
32,  2·0 (1·4, 2·8) 
68,  4·2 (3·3, 5·3) 
242,  14·9 (13·3, 16·8) 
Diagnosed 1985-2006 * 
  Died <=3 years 
2187 
821,  37·5 (35·5, 39·6) 
1466 
623,  42·5 (39·9, 45·0) 
Diagnosed 1985-2004 * 
  Died <=5 years 
1990 
903,  45·4 (43·2, 47·6) 
1337 
661, 49·4 (46·7, 52·1) 
*subset of patients diagnosed 1985-2008 
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TABLE 3 - Osteosarcoma: Effect of area deprivation markers and age on mortality (multivariable 
analysis)  
Time period Variable OR       (95% CI)           p value 
<=3 months % Unemployment 
Males vs Females 
Age 0-14 years 
        15-19  
        20-39 
        40-49 
1·06  (1·01, 1·10)          0·02 
1·20 (0·643, 2·24)         0·56 
- 
2·22 (0·752, 6·57)         0·14 
3·23 (1·17, 8·91)           0·02 
10·8 (3·67, 31·53)       <0·001 
<=6 months % Household without car 
Males vs Females 
Age 0-14 years 
        15-19  
        20-39 
        40-49 
1·02 (1·00, 1·03)            0·02 
1·29 (0·840, 1·98)          0·24 
- 
1·25 (0·678, 2·33)            0·46 
1·51 (0·848, 2·69)            0·16 
4·23 (2·15, 8·28)        <0·001 
<=6 months % Unemployment 
Males vs Females 
Age 0-14 years 
        15-19  
        20-39 
        40-49 
1·04 (1·01, 1·08)            0·02 
1·29 (0·843, 1·99)          0·23 
- 
1·25 (0·673, 2·32)          0·47 
1·55 (0·868, 2·76)          0·13 
4·23 (2·16, 8·29)         <0·001 
<=1 year % Unemployment 
Males vs Females 
Age 0-14 years 
        15-19  
        20-39 
        40-49 
1·04 (1·02, 1·06)           0·001 
1·14 (0·883, 1·47)         0·31 
- 
1·02 (0·725, 1·43)         0·90 
1·12 (0·815, 1·56)         0·46 
2·57 (1·67, 3·94)         <0·001 
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FIGURE 1a - Osteosarcoma cohort: Cumulative mortality at time after diagnosis by age group.              
(3 year and 5 year follow up restricted to those diagnosed 1985-2006 and 1985-2004 respectively) 
 
 
 
FIGURE 1b - Ewing Sarcoma cohort: Cumulative mortality at time after diagnosis by age group.             
(3 year and 5 year follow up restricted to those diagnosed 1985-2006 and 1985-2004 respectively) 
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FIGURE 2a - Osteosarcoma: Effect of area on mortality (compared to Inner London) 
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FIGURE 2b - Ewing Sarcoma: Effect of area on mortality (compared to Inner London) 
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SUPPLEMENTAL TABLE S1 -- Osteosarcoma: Effect of age, sex and area deprivation markers on mortality (univariable analysis) in each time period 
 <=3 months 
 OR  (95% CI)    p-value 
<=6 months 
OR  (95% CI)     p-value  
<=1 year 
OR  (95% CI)     p-value 
<=3 years 
OR  (95% CI)     p-value 
<=5 years 
OR  (95% CI)     p-value 
Age 0-14 years 
      15-19 
      20-39 
      40-49  
- 
2·27 (0·77, 6·66)    0·14 
3·33 (1·21, 9·13)    0·02 
10·2 (3·49, 29·6)<0·001 
- 
1·24 (0·67, 2·30)   0·49 
1·56 (0·88, 2·77)   0·13 
3·99 (2·05, 7·79)<0·001 
- 
1·03 (0·73, 1·44)  0·87 
1·14 (0·83, 1·58)  0·41 
2·47 (1·62, 3·78)<0·001 
- 
0·96 (0·77, 1·21)   0·75 
1·01 (0·81, 1·25)   0·94 
1·61 (1·14, 2·27)  0·007 
- 
1·10 (0·87, 1·37)   0·43 
1·00 (0·80, 1·25)   0·98 
1·42 (0·99, 2·05)   0·06 
Males 
Females 
- 
1·05 (0·57, 1·94)    0·89 
- 
1·19 (0·78, 1·83)   0·40 
- 
1·09 (0·85, 1·41)  0·49 
- 
0·79 (0·67, 0·95)   0·01 
- 
0·76 (0·63, 0·91)  0·002 
Townsend score* 1·08 (0·98, 1·18)    0·08 1·06 (0·99, 1·12)   0·08 1·04 (1·00, 1·07)  0·04 0·99 (0·96, 1·02)   0·42 0·98 (0·96, 1·01)   0·24 
% Unemployment 1·05 (1·01, 1·10)    0·02 1·04 (1·00, 1·07)   0·02 1·03 (1·01, 1·06)  0·002 1·00 (0·99, 1·02)   0·83 1·00 (0·98, 1·01)   0·99 
% HH Overcrowded 0·98 (0·86, 1·13)    0·82 0·97 (0·88, 1·07)   0·49 1·00 (0·95, 1·05)  0·97 0·97 (0·94, 1·01)   0·19 0·97 (0·93, 1·00)   0·08 
% HH property not owned 1·01 (0·99, 1·03)    0·09 1·01 (0·99, 1·02)   0·06 1·00 (0·99, 1·01)  0·09 1·00 (0·99, 1·01)   0·27 1·00 (0·99, 1·01)   0·39 
% HH without car 1·02 (0·99, 1·04)    0·08 1·02 (1·00, 1·03)   0·02 1·01 (1·00, 1·02)  0·04 1·00 (0·99, 1·01)   0·32 1·00 (0·99, 1·01)   0·17 
Population density 
(0-49 years) 
 
1·00 (0·99, 1·01)    0·92 
 
1·00 (0·99, 1·01)    0·88 
 
1·00 (0·99, 1·01)  0·51 
 
1·00 (0·99, 1·01)   0·27 
 
1·00 (0·99, 1·01)   0·05 
Population density (All 
age) 
1·00 (0·99, 1·01)    0·95     1·00 (0·99, 1·01)    0·99          1·00 (0·99, 1·01)  0·61         1·00 (0·99, 1·01)   0·25          1·00 (0·99, 1·01)   0·05 
* increase in score=increase in deprivation 
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SUPPLEMENTAL TABLE S2 - Ewing Sarcoma: Effect of age, sex and area deprivation markers on mortality (univariable analysis) in each time period 
 <=3 months 
 OR  (95% CI)     p-value 
<=6 months 
OR  (95% CI)     p-value  
<=1 year 
OR  (95% CI)     p-value 
<=3 years 
OR  (95% CI)     p-value 
<=5 years 
OR  (95% CI)     p-value 
Age 0-14 years 
       15-19 
       20-39 
       40-49  
- 
2·13 (0·47, 9·58)      0·32 
9·02 (2·66, 30·54)<0·001 
15·99 (3·74, 68·4)<0·001 
- 
1·48 (0·67, 3·28)      0·33 
3·81 (2·00, 7·28)  <0·001 
5·24 (2·02, 13·61)<0·001 
- 
2·27 (1·54, 3·36)  <0·001 
3·09 (2·16, 4·44)  <0·001 
6·34 (3·61, 11·2)  <0·001 
- 
2·67 (2·04, 3·50)  <0·001 
2·59 (2·00, 3·36)  <0·001 
7·19 (3·96, 13·08)<0·001 
- 
2·69 (2·03, 3·56)  <0·001 
2·54 (1·94, 3·31)  <0·001 
7·08 (3·66, 13·71)<0·001 
Males 
Females 
- 
0·68 (0·32, 1·44)      0·31 
- 
0·66 (0·39, 1·11)      0·12 
- 
0·94 (0·71, 1·24)      0·66 
- 
0·97 (0·78, 1·20)      0·81 
- 
1·06 (0·86, 1·32)      0·58 
Townsend score* 1·01 (0·91, 1·12)      0·86 0·96 (0·89, 1·04)      0·36 1·03 (0·99, 1·07)      0·18 1·00 (0·97, 1·04)      0·88 0·99 (0·96, 1·03)      0·83 
% Unemployment 1·01 (0·95, 1·08)      0·77 0·97 (0·92, 1·03)      0·35 1·02 (0·99, 1·05)      0·11 1·00 (0·98, 1·02)      0·73 0·99 (0·98, 1·02)      0·76 
% HH Overcrowded 0·98 (0·83, 1·16)      0·81 1·06 (0·97, 1·16)      0·19 1·04 (0·98, 1·10)      0·19 0·99 (0·94, 1·04)      0·62 0·98 (0·93, 1·03)      0·46 
% HH property  
not owned 
 
1·00 (0·98, 1·02)      0·89 
 
0·99 (0·98, 1·01)      0·21 
 
1·00 (0·99, 1·01)      0·31 
 
1·00 (0·99, 1·01)      0·79 
 
0·99 (0·99, 1·01)      0·85 
% HH without car 1·00 (0·98, 1·03)      0·72 0·99 (0·98, 1·01)      0·38 1·00 (0·99, 1·01)      0·28 1·00 (0·99, 1·01)      0·94 1·00 (0·99, 1·01)      0·99 
Population density 
 (0-49 years) 
 
1·00 (0·99, 1·01)      0·37 
 
1·00 (0·99, 1·01)      0·81 
 
0·99 (0·99, 1·01)      0·16 
 
0·99 (0·99, 1·01)      0·08 
 
0·99 (0·99, 1·01)      0·21 
Population density 
(All age) 
 
1·00 (0·99, 1·01)      0·38 
 
1·00 (0·99, 1·01)      0·94 
 
0·99 (0·99, 1·01)      0·09 
 
0·99 (0·99, 1·01)      0·06 
 
0·99 (0·99, 1·01)      0·17 
* increase in score=increase in deprivation 
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SUPPPLEMENTAL TABLE S3 - Osteosarcoma: Effect of area (compared to Inner London) on mortality at 6 months post diagnosis, adjusted for age and sex 
and Townsend score, unemployment or non-car ownership (area sorted by OR when adjusted for age and sex). 
  
Adjusted for age and sex 
Odds Ratio (95% CI) 
Adjusted for age, sex 
and Townsend score 
Odds Ratio (95% CI) 
Adjusted for age, sex 
and unemployment 
Odds Ratio (95% CI) 
Adjusted for age, sex 
and non-car ownership 
Odds Ratio (95% CI) 
Accessible rural 0·783 (0·079, 7·73) 1·71 (0·162, 18·09) 1·08 (0·107, 10·87) 2·18 (0·206, 23·18) 
Inner London 1 1 1 1 
Principal metropolitan cities 1·24 (0·273, 5·66) 1·53 (0·333, 7·02) 1·14 (0·250, 5·27) 1·36 (0·298, 6·26) 
Outer London 1·46 (0·359, 6·00) 2·30 (0·544, 9·76) 1·76 (0·428, 7·30) 2·84 (0·663, 12·19) 
Industrial districts 1·49 (0·404, 5·54) 2·64 (0·673, 10·41) 1·77 (0·474, 6·63) 3·00 (0·769, 11·76) 
Accessible urban/rural 1·69 (0·462, 6·18) 3·64 (0·891, 14·88) 2·29 (0·610, 8·60) 4·87 (1·17, 20·33) 
Resort port and retirement 2·14 (0·524, 8·78) 4·14 (0·937, 18·29) 2·70 (0·649, 11·23) 4·68 (1·07, 20·46) 
Remoter urban/rural 2·34 (0·508, 10·79) 5·01 (0·987, 25·43) 3·16 (0·670, 14·94) 6·41 (1·25, 32·79) 
Small non-metropolitan 
cities 
2·36 (0·513, 10·88) 4·20 (0·866, 20·39) 2·96 (0·635, 13·81) 4·57 (0·951, 21·95) 
Remoter rural 2·65 (0·686, 10·26) 5·24 (1·24, 22·05) 3·36 (0·856, 13·24) 6·74 (1·58, 28·77) 
Districts with new towns 2·66 (0·646, 10·94) 4·65 (1·07, 20·19) 3·26 (0·783, 13·57) 5·72 (1·30, 25·09) 
Other metropolitan cities 2·68 (0·773, 9·29) 4·11 (1·14, 14·73) 2·91 (0·838, 10·13) 4·34 (1·22, 15·45) 
Large non-metropolitan 
cities 
2·78 (0·721, 10·77) 4·04 (1·02, 16·01) 3·01 (0·775, 11·68) 4·03 (1·02, 15·83) 
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SUPPLEMENTAL TABLE S4 - Osteosarcoma: Effect of area (compared to Inner London) on mortality at 1 year post diagnosis, adjusted for age and sex and 
Townsend score, unemployment or non-car ownership (area sorted by OR when adjusted for age and sex). 
  
Adjusted for age and sex 
Odds Ratio (95% CI) 
Adjusted for age, sex 
and Townsend score 
Odds Ratio (95% CI) 
Adjusted for age, sex 
and unemployment 
Odds Ratio (95% CI) 
Adjusted for age, sex 
and non-car ownership 
Odds Ratio (95% CI) 
Inner London 1 1 1 1 
Accessible rural 1·66 (0·563, 4·91) 3·19 (1·02, 9·94) 2·23 (0·746, 6·69) 3·36 (1·07, 10·52) 
Outer London 1·73 (0·768, 3·90) 2·53 (1·09, 5·86) 2·50 (0·904, 4·67) 2·73 (1·17, 6·36) 
Principal metropolitan cities 1·79 (0·773, 4·16) 2·16 (0·927, 5·06) 1·69 (0·725, 3·95) 1·98 (0·850, 4·61) 
Districts with new towns 1·88 (0·776, 4·59) 2·99 (1·19, 7·52) 2·26 (0·923, 5·55) 3·17 (1·25, 8·02) 
Accessible urban/rural 1·90 (0·890, 4·06) 3·61 (1·57, 8·30) 2·51 (1·15, 5·47) 3·91 (1·68, 9·09) 
Large non-metropolitan 
cities 
2·08 (0·904, 4·81) 2·87 (1·22, 6·74) 2·26 (0·975, 5·24) 2·73 (1·16, 6·37) 
Industrial districts 2·10 (0·993, 4·47) 3·40 (1·54, 7·52) 2·46 (1·15, 5·27) 3·41 (1·54, 7·52) 
Resort port and retirement 2·13 (0·923, 4·92) 3·70 (1·52, 8·97) 2·63 (1·13, 6·15) 3·65 (1·51, 8·80) 
Remoter rural 2·26 (0·991, 5·15) 4·08 (1·66, 9·61) 2·81 (1·21, 6·48) 4·27 (1·76, 10·36) 
Other metropolitan cities 2·58 (1·23, 5·40) 3·72 (1·73, 7·99) 2·81 (1·33, 5·91) 3·63 (1·70, 7·75) 
Small non-metropolitan 
cities 
2·90 (1·19, 7·04) 4·73 (1·88, 11·88) 3·56 (1·45, 8·73) 4·58 (1·83, 11·45) 
Remoter urban/rural 2·92 (1·20, 7·10) 5·61 (2·16, 14·55) 3·90 (1·58, 9·65) 5·89 (2·26, 15·32) 
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SUPPLEMENTAL FIGURE S1 - Area unemployment and 
non-car ownership 
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SUPPLEMENTAL FIGURE S2 - Area unemployment and 
non-car ownership by area type 
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Highlights 
 It is not known if socio-economic factors or residence in less urban areas are 
related to worse outcome in osteosarcoma or Ewing sarcoma patients.   
 This study investigated if early risk of death from osteosarcoma or Ewing 
sarcoma is determined by residence in more deprived or less urban areas.  
 Risk of dying early from a diagnosis of osteosarcoma was greater for patients 
who resided in areas with higher rates of unemployment.  
 For both osteosarcoma and Ewing sarcoma greater risk of dying early was 
associated with more rural area types.  
 Early diagnosis or access to care may be determined by socio-economic 
factors or distance from a specialist treatment centre.   
 
 
